Birdwatch Note Rating
2023-06-27 14:44:52 UTC - HELPFUL
Rated by Participant: 98B19E6CFD07DFC5A1E0A41A56336912AEAB9DC23AEE3FE337B1E5126F6DD624
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details